Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("BYSTRYN, Jean-Claude")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 20 of 20

  • Page / 1
Export

Selection :

  • and

Heterogeneous antibody response to polyvalent melanoma vaccines in syngeneic miceJOHNSTON, Dean; BYSTRYN, Jean-Claude.Cancer immunology and immunotherapy. 2005, Vol 54, Num 4, pp 345-350, issn 0340-7004, 6 p.Article

Topical imiquimod is a potent adjuvant to a weakly-immunogenic protein prototype vaccineJOHNSTON, Dean; BYSTRYN, Jean-Claude.Vaccine. 2006, Vol 24, Num 11, pp 1958-1965, issn 0264-410X, 8 p.Article

A novel explanation for acantholysis in pemphigus vulgaris : The basal cell shrinkage hypothesisBYSTRYN, Jean-Claude; GRANDO, Sergei A.Journal of the American Academy of Dermatology. 2006, Vol 54, Num 3, pp 513-516, issn 0190-9622, 4 p.Article

Intravenous immunoglobulin selectively decreases circulating autoantibodies in pemphigusCZERNIK, Annette; BEUTNER, Ernst H; BYSTRYN, Jean-Claude et al.Journal of the American Academy of Dermatology. 2008, Vol 58, Num 5, pp 796-801, issn 0190-9622, 6 p.Article

Laryngeal and nasal involvement in pemphigus vulgarisHALE, Elizabeth K; BYSTRYN, Jean-Claude.Journal of the American Academy of Dermatology. 2001, Vol 44, Num 4, pp 609-611, issn 0190-9622Article

IVIg treatment of pemphigus : How it works & how to use itBYSTRYN, Jean-Claude; RUDOLPH, Jennifer L.Journal of investigative dermatology. 2005, Vol 125, Num 6, pp 1093-1098, issn 0022-202X, 6 p.Article

PemphigusBYSTRYN, Jean-Claude; RUDOLPH, Jennifer L.Lancet (British edition). 2005, Vol 366, Num 9479, pp 61-73, issn 0140-6736, 13 p.Article

Treatment of pemphigus with intravenous immunoglobulinBYSTRYN, Jean-Claude; JIAO, Diane; NATOW, Steven et al.Journal of the American Academy of Dermatology. 2002, Vol 47, Num 3, pp 358-363, issn 0190-9622, 6 p.Article

Interleukin-2/liposomes potentiate immune responses to a soluble protein cancer vaccine in miceJOHNSTON, Dean; REYNOLDS, Sandra R; BYSTRYN, Jean-Claude et al.Cancer immunology and immunotherapy. 2006, Vol 55, Num 4, pp 412-419, issn 0340-7004, 8 p.Article

IVIg selectively and rapidly decreases circulating pathogenic autoantibodies in pemphigus vulgarisBYSTRYN, Jean-Claude; JIAO, Diane.Autoimmunity (Print). 2006, Vol 39, Num 7, pp 601-607, issn 0891-6934, 7 p.Article

Vaccines for melanomaBYSTRYN, Jean-Claude.Dermatologic clinics. 2002, Vol 20, Num 4, issn 0733-8635, x, 717-725 [10 p.]Article

Antibodies to desmoglein 1 and 3, and the clinical phenotype of pemphigus vulgarisJAMORA, Maria Jasmin J; JIAO, Diane; BYSTRYN, Jean-Claude et al.Journal of the American Academy of Dermatology. 2003, Vol 48, Num 6, pp 976-977, issn 0190-9622, 2 p.Article

Effect of intravenous immunoglobulin with or without cytotoxic drugs on pemphigus intercellular antibodiesLOLIS, Margarita; TOOSI, Siavash; CZERNIK, Annette et al.Journal of the American Academy of Dermatology. 2011, Vol 64, Num 3, pp 484-489, issn 0190-9622, 6 p.Article

Improved identification of potentially dangerous pigmented skin lesions by computerized image analysisJAMORA, Maria Jasmin; WAINWRIGHT, Brent D; MEEHAN, Shane A et al.Archives of dermatology (1960). 2003, Vol 139, Num 2, pp 195-198, issn 0003-987X, 4 p.Article

Pemphigus vulgaris with involvement of the cervix treated using thalidomide therapyROWILSON CUNHA, Paulo; RODRIGUES DE OLIVEIRA, Josenildo; SALLES, Maria José et al.International journal of dermatology. 2004, Vol 43, Num 9, pp 682-684, issn 0011-9059, 3 p.Article

Vaccine-induced CD8+ T-cell responses to MAGE-3 correlate with clinical outcome in patients with melanomaREYNOLDS, Sandra R; ZELENIUCH-JACQUOTTE, Anne; SHAPIRO, Richard L et al.Clinical cancer research. 2003, Vol 9, Num 2, pp 657-662, issn 1078-0432, 6 p.Article

Identification of HLA-A*03, A*11 and B*07-restricted melanoma-associated peptides that are immunogenic in vivo by vaccine-induced immune response (VIIR) analysisREYNOLDS, Sandra R; CELIS, Esteban; SETTE, Alessandro et al.Journal of immunological methods. 2000, Vol 244, Num 1-2, pp 59-67, issn 0022-1759Article

Tumid lupus erythematosus: Criteria for classification with immunohistochemical analysisALEXIADES-ARMENAKAS, Macrene R; BALDASSANO, Marisa; BINCE, Benji et al.Arthritis care and research. 2003, Vol 49, Num 4, pp 494-500, issn 0893-7524, 7 p.Article

Reliability and Convergent Validity of Two Outcome Instruments for PemphigusROSENBACH, Misha; MURRELL, Dedee F; PANDYA, Amit G et al.Journal of investigative dermatology. 2009, Vol 129, Num 10, pp 2404-2410, issn 0022-202X, 7 p.Article

Changes in the presence of multiple markers of circulating Melanoma cells correlate with clinical outcome in patients with melanomaREYNOLDS, Sandra R; ALBRECHT, Jeff; SHAPIRO, Richard L et al.Clinical cancer research. 2003, Vol 9, Num 4, pp 1497-1502, issn 1078-0432, 6 p.Article

  • Page / 1